International healthcare nonprofit PATH is partnering up with SD Biosensor to develop and commercialize an in vitro diagnostic that screens out patients who may have serious adverse reactions to a ...
On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results